Tag Archives: immunoglobulin

Research review: Immunoglobulin therapy for ME/CFS

Posted on 11/15/2021 by wames

Back to the Future? Immunoglobulin therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, by  Helen Brownlie and Nigel Speight in Healthcare 2021, 9(11), 1546; [doi.org/10.3390/healthcare9111546]   12 Nov 2021 (This article belongs to the Special Issue ME/CFS – the Severely and Very Severely Affected)   … Continue reading →

Posted in News | Tagged , , , , , , , , | Comments Off on Research review: Immunoglobulin therapy for ME/CFS

Severe ME in children

Posted on 07/17/2020 by wames

Severe ME in children, by Nigel Speight in Healthcare Vol 8, #3 p 211, July 14, 2020 [This article belongs to the Special Issue ME/CFS]   Guideline abstract The current problem regarding Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS) is the … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , | Comments Off on Severe ME in children

IgG stimulated β2 adrenergic receptor activation is attenuated in patients with ME/CFS

Posted on 02/24/2020 by wames

IgG stimulated β2 adrenergic receptor activation is attenuated in patients with ME/CFS, by Jelka Hartwig, Franziska Sotzny, Sandra Bauer, Harald Heidecke, Gabriela Riemekasten, Duska Dragund, Christian Meisel, Claudia Dames, Patricia Grabowski, Carmen Scheibenbogen in Brain, Behavior, & Immunity – Health, 5 … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , | Comments Off on IgG stimulated β2 adrenergic receptor activation is attenuated in patients with ME/CFS